AFT Pharmaceuticals rises after firm says on track to meet FY27 revenue target

AFT Pharmaceuticals

25/09/2025 24:46

** Shares of New Zealand's AFT Pharmaceuticals AFT.NZ rise as much as 2.7% to NZ$2.63, their highest level since September 5

** Pharmaceutical firm says sales tracking in line with NZ$300 million ($174.45 million) FY27 revenue target

** Says clinical trial supports potential patient benefits of iron IV development project and an active licensing programme is supporting growth

** About 24,000 shares change hands, 1.7 times the 30-day avg

** Stock down 6.9% YTD, including session's moves

($1 = 1.7197 New Zealand dollars)

 (Reporting by Anjali Singh in Bengaluru)

 ((anjali.singh2@thomsonreuters.com;))